miR-142-3p Controls the Specification of Definitive Hemangioblasts during Ontogeny

被引:61
|
作者
Nimmo, Rachael [1 ]
Ciau-Uitz, Aldo [2 ]
Ruiz-Herguido, Cristina [3 ]
Soneji, Shamit [1 ]
Bigas, Anna [3 ]
Patient, Roger [2 ]
Enver, Tariq [1 ]
机构
[1] UCL Canc Inst, Stem Cell Lab, London WC1E 6BT, England
[2] Univ Oxford, Weatherall Inst Mol Med, Mol Haematol Unit, Oxford OX3 9DS, England
[3] PRBB, Inst Hosp Mar Invest Med IMIM, Canc Res Program, Barcelona 08003, Spain
关键词
STEM-CELL DEVELOPMENT; TGF-BETA INHIBITION; MICRORNA BIOGENESIS; AORTIC ENDOTHELIUM; EMBRYONIC BLOOD; UP-REGULATION; MOUSE; HEMATOPOIESIS; ADULT; LINEAGE;
D O I
10.1016/j.devcel.2013.06.023
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Hematopoietic stem cells (HSCs) emerge during embryogenesis from hemogenic endothelium, but it remains unclear how the HSC lineage is initially established from mesoderm during ontogeny. In Xenopus, the definitive hemangioblast precursors of the HSC lineage have been identified in dorsal lateral plate (DLP) mesoderm, and a transcriptional gene regulatory network (GRN) controlling hemangioblast programming has been elucidated. Herein, we identify an essential role for microRNAs (miRNAs) in establishing the mesodermal lineage leading to both HSC emergence and vasculogenesis and determine that a single miRNA, miR-142-3p, is primarily responsible for initiation of definitive hemangioblast specification. miR-142-3p forms a double-negative gate unlocking entry into the hemangioblast program, in part by inhibiting TGF beta signaling. Our results table miR-142-3p as a master regulator of HSC lineage specification, sitting at the apex of the hierarchy programming the adult hemangioblast, thus illustrating that miRNAs can act as instructive determinants of cell fate during development.
引用
收藏
页码:237 / 249
页数:13
相关论文
共 50 条
  • [1] The Expression of miR-142-3p in Fatty Liver
    Henderson, Wendy A.
    Martino, Angela C.
    Del Valle-Pinero, Arseima Y.
    Peace, R. Michael
    Abey, Sarah
    GASTROENTEROLOGY, 2012, 142 (05) : S1021 - S1021
  • [2] MiR-142-3p in leukaemogenesis: tumour suppressor or oncomiR?
    Lagrange, Brice
    Martin, Romain Z.
    Droin, Nathalie
    Solary, Eric
    Bastie, Jean-Noel
    Delva, Laurent
    M S-MEDECINE SCIENCES, 2013, 29 (6-7): : 574 - 576
  • [3] miR-142-3p expression correlates with operational tolerance
    Helene Myrvang
    Nature Reviews Nephrology, 2012, 8 (4) : 194 - 194
  • [4] 大鼠miR-142-3p、miR-145-3p表达模式分析
    吴慧
    赵宇龙
    王艳红
    房兴堂
    陈宏
    张春雷
    天津医药, 2016, 44 (04) : 434 - 437
  • [5] miR-142-3p Prevents Macrophage Differentiation during Cancer-Induced Myelopoiesis
    Sonda, Nada
    Simonato, Francesca
    Peranzoni, Elisa
    Cali, Bianca
    Bortoluzzi, Stefania
    Bisognin, Andrea
    Wang, Ena
    Marincola, Francesco M.
    Naldini, Luigi
    Gentner, Bernhard
    Trautwein, Christian
    Sackett, Sara Dutton
    Zanovello, Paola
    Molon, Barbara
    Bronte, Vincenzo
    IMMUNITY, 2013, 38 (06) : 1236 - 1249
  • [6] miR-142-3p balances proliferation and differentiation of mesenchymal cells during lung development
    Carraro, Gianni
    Shrestha, Amit
    Rostkovius, Jana
    Contreras, Adriana
    Chao, Cho-Ming
    El Agha, Elie
    MacKenzie, Breanne
    Dilai, Salma
    Guidolin, Diego
    Taketo, Makoto Mark
    Guenther, Andreas
    Kumar, Maya E.
    Seeger, Werner
    De Langhe, Stijn
    Barreto, Guillermo
    Bellusci, Saverio
    DEVELOPMENT, 2014, 141 (06): : 1272 - U180
  • [7] miR-142-3p is associated with aberrant WNT signaling during airway remodeling in asthma
    Bartel, Sabine
    Carraro, Gianni
    Alessandrini, Francesca
    Krauss-Etschmann, Susanne
    Ricciardolo, Fabio Luigi Massimo
    Bellusci, Saverio
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2018, 315 (02) : L328 - L333
  • [8] Circulating miR-142-3p levels in patients with systemic sclerosis
    Makino, K.
    Jinnin, M.
    Kajihara, I.
    Honda, N.
    Sakai, K.
    Masuguchi, S.
    Fukushima, S.
    Inoue, Y.
    Ihn, H.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2012, 37 (01) : 34 - 39
  • [9] miR-142-3p promotes osteoblast differentiation by modulating Wnt signaling
    Hu, Weihua
    Ye, Yaping
    Zhang, Weikai
    Wang, Jiang
    Chen, Anmin
    Guo, Fengjing
    MOLECULAR MEDICINE REPORTS, 2013, 7 (02) : 689 - 693
  • [10] MiR-142-3p is a paracrine mediator between T cells and endothelium during allograft rejection
    Gupta, Shashi K.
    Thum, Thomas
    CARDIOVASCULAR RESEARCH, 2017, 113 (05) : 431 - 433